Compare Novavax Inc (NVAX) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Roblox Corp — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Roblox Corp trades at $52.5 (market cap $38.13B). The key difference: Roblox Corp is far larger — about 29.3× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| NVAX | RBLX | |
|---|---|---|
Market Cap | $1.30B | $38.13B |
Sector | Health | Media |
52-Week High | $11.19 | $141.56 |
52-Week Low | $6.22 | $41.30 |
Enterprise Value | $800.50M | $36.71B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
